251 related articles for article (PubMed ID: 32129948)
21. Optimal extent of lymphadenectomy for gastric adenocarcinoma: A 7-institution study of the U.S. gastric cancer collaborative.
Randle RW; Swords DS; Levine EA; Fino NF; Squires MH; Poultsides G; Fields RC; Bloomston M; Weber SM; Pawlik TM; Jin LX; Spolverato G; Schmidt C; Worhunsky D; Cho CS; Maithel SK; Votanopoulos KI
J Surg Oncol; 2016 Jun; 113(7):750-5. PubMed ID: 26996496
[TBL] [Abstract][Full Text] [Related]
22. Modified versus standard D2 lymphadenectomy in total gastrectomy for nonjunctional gastric carcinoma with lymph node metastasis.
Galizia G; Lieto E; De Vita F; Castellano P; Ferraraccio F; Zamboli A; Mabilia A; Auricchio A; De Sena G; De Stefano L; Cardella F; Barbarisi A; Orditura M
Surgery; 2015 Feb; 157(2):285-96. PubMed ID: 25532433
[TBL] [Abstract][Full Text] [Related]
23. A comparison of the operative outcomes of D1 and D2 gastrectomy performed at a single Western center with multiple surgeons: a retrospective analysis with propensity score matching.
Lam S; Tan E; Menezes A; Martin D; Gallagher J; Storey D; Sandroussi C
World J Surg Oncol; 2018 Jul; 16(1):136. PubMed ID: 29986713
[TBL] [Abstract][Full Text] [Related]
24. D2 Lymphadenectomy for Gastric Adenocarcinoma: Long-term Results and the Impact of Surgeon Experience on the Survival Rates.
Tudor S; Dumitrascu T; Manuc M; Trandafir B; Ionescu M; Popescu I; Herlea V; Vasilescu C
Chirurgia (Bucur); 2018; 113(6):772-779. PubMed ID: 30596365
[No Abstract] [Full Text] [Related]
25. Extended lymphadenectomy in elderly and/or highly co-morbid gastric cancer patients: A retrospective multicenter study.
Rausei S; Ruspi L; Rosa F; Morgagni P; Marrelli D; Cossu A; Cananzi FC; Lomonaco R; Coniglio A; Biondi A; Cipollari C; Graziosi L; Fumagalli U; Casella F; Bertoli P; di Leo A; Alfieri S; Vittimberga G; Roviello F; Orsenigo E; Quagliuolo V; Montemurro S; Baiocchi G; Persiani R; Bencivenga M; Donini A; Rosati R; Sansonetti A; Ansaloni L; Zanoni A; Galli F; Dionigi G;
Eur J Surg Oncol; 2016 Dec; 42(12):1881-1889. PubMed ID: 27266816
[TBL] [Abstract][Full Text] [Related]
26. Comparison of long term survival outcomes between D1+ and D2 lymph node dissection for ≥ pT2 or pN+ gastric carcinoma: A large scale case-control study using propensity score matching.
Kang JH; Ryu SY; Jung MR; Jeong O
Eur J Surg Oncol; 2020 Jul; 46(7):1239-1246. PubMed ID: 32331983
[TBL] [Abstract][Full Text] [Related]
27. Surgical outcomes of gastrectomy with D1 lymph node dissection performed for patients with unfavorable clinical conditions.
Ramos MFKP; Pereira MA; Dias AR; Yagi OK; Zaidan EP; Ribeiro-Júnior U; Zilberstein B; Cecconello I
Eur J Surg Oncol; 2019 Mar; 45(3):460-465. PubMed ID: 30497814
[TBL] [Abstract][Full Text] [Related]
28. Extent of lymphadenectomy has no impact on postoperative complications after gastric cancer surgery in Sweden.
Kung CH; Song H; Ye W; Nilsson M; Johansson J; Rouvelas I; Irino T; Lundell L; Tsai JA; Lindblad M
Chin J Cancer Res; 2017 Aug; 29(4):313-322. PubMed ID: 28947863
[TBL] [Abstract][Full Text] [Related]
29. A prospective observational study of 468 patients undergoing D2 or D3 lymphadenectomy for gastric cancer.
Bostanci EB; Ozer I; Ercan M; Ulas M; Koc U; Karaman K; Dalgic T; Ozogul Y; Akoglu M
Hepatogastroenterology; 2013 May; 60(123):624-7. PubMed ID: 23635437
[TBL] [Abstract][Full Text] [Related]
30. Do patients with pN0 gastric cancer benefit from prophylactic extended lymphadenectomy?
Sun D; Gong R; Wu H
Surg Oncol; 2012 Mar; 21(1):e7-11. PubMed ID: 22071221
[TBL] [Abstract][Full Text] [Related]
31. Does D3 surgery offer a better survival outcome compared to D1 surgery for gastric cancer? A result based on a hospital population of two decades as taking D2 surgery for reference.
Zhang H; Liu C; Wu D; Meng Y; Song R; Lu P; Wang S
BMC Cancer; 2010 Jun; 10():308. PubMed ID: 20565910
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of lymph node dissection in gastric cancer.
de Manzoni G; Verlato G; Guglielmi A; Laterza E; Genna M; Cordiano C
Br J Surg; 1996 Nov; 83(11):1604-7. PubMed ID: 9014687
[TBL] [Abstract][Full Text] [Related]
33. Extent of lymph node dissection for adenocarcinoma of the stomach.
Mocellin S; McCulloch P; Kazi H; Gama-Rodrigues JJ; Yuan Y; Nitti D
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD001964. PubMed ID: 26267122
[TBL] [Abstract][Full Text] [Related]
34. Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial.
Kulig J; Popiela T; Kolodziejczyk P; Sierzega M; Szczepanik A;
Am J Surg; 2007 Jan; 193(1):10-5. PubMed ID: 17188080
[TBL] [Abstract][Full Text] [Related]
35. [D2 lymph node dissection in gastric cancer surgery: long term results--analysis of an experience with 227 patients].
Vasilescu C; Herlea V; Tidor S; Ivanov B; Stănciulea O; Mănuc M; Gheorghe C; Ionescu M; Diculescu M; Popescu I
Chirurgia (Bucur); 2006; 101(4):375-84. PubMed ID: 17059148
[TBL] [Abstract][Full Text] [Related]
36. Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study.
Roukos DH; Lorenz M; Encke A
Surgery; 1998 May; 123(5):573-8. PubMed ID: 9591011
[TBL] [Abstract][Full Text] [Related]
37. Short-term and long-term risk factors in gastric cancer.
Verlato G; Marrelli D; Accordini S; Bencivenga M; Di Leo A; Marchet A; Petrioli R; Zoppini G; Muggeo M; Roviello F; de Manzoni G
World J Gastroenterol; 2015 Jun; 21(21):6434-43. PubMed ID: 26074682
[TBL] [Abstract][Full Text] [Related]
38. Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer.
Wu CW; Hsiung CA; Lo SS; Hsieh MC; Shia LT; Whang-Peng J
Br J Surg; 2004 Mar; 91(3):283-7. PubMed ID: 14991627
[TBL] [Abstract][Full Text] [Related]
39. Gastrectomy with Extended Lymphadenectomy: a North American Perspective.
Gosselin-Tardif A; Lie J; Nicolau I; Molina JC; Cools-Lartigue J; Feldman L; Spicer J; Mueller C; Ferri L
J Gastrointest Surg; 2018 Mar; 22(3):414-420. PubMed ID: 29124550
[TBL] [Abstract][Full Text] [Related]
40. [Clinical value of superior mesenteric vein (No.14v) lymph node dissection in D2 gastrectomy for locally advanced distal gastric cancer].
Lu W; Zeng X; Li N; Liu H
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1136-1141. PubMed ID: 30370512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
